BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 25167547)

  • 41. Transferable and Interpretable Treatment Effectiveness Prediction for Ovarian Cancer via Multimodal Deep Learning.
    Nguyen E; Cui Z; Kokaraki G; Carlson J; Liu Y
    AMIA Annu Symp Proc; 2023; 2023():550-558. PubMed ID: 38222355
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Application of EfficientNet-B0 and GRU-based deep learning on classifying the colposcopy diagnosis of precancerous cervical lesions.
    Chen X; Pu X; Chen Z; Li L; Zhao KN; Liu H; Zhu H
    Cancer Med; 2023 Apr; 12(7):8690-8699. PubMed ID: 36629131
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Computer-aided diagnosis of cervical dysplasia using colposcopic images.
    Ma JH; You SF; Xue JS; Li XL; Chen YY; Hu Y; Feng Z
    Front Oncol; 2022; 12():905623. PubMed ID: 35992807
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of a prognostic prediction support system for cervical intraepithelial neoplasia using artificial intelligence-based diagnosis.
    Takahashi T; Matsuoka H; Sakurai R; Akatsuka J; Kobayashi Y; Nakamura M; Iwata T; Banno K; Matsuzaki M; Takayama J; Aoki D; Yamamoto Y; Tamiya G
    J Gynecol Oncol; 2022 Sep; 33(5):e57. PubMed ID: 35712970
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cervical Lesion Classification Method Based on Cross-Validation Decision Fusion Method of Vision Transformer and DenseNet.
    Li P; Wang X; Liu P; Xu T; Sun P; Dong B; Xue H
    J Healthc Eng; 2022; 2022():3241422. PubMed ID: 35607393
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Artificial Intelligence in Cervical Cancer Screening and Diagnosis.
    Hou X; Shen G; Zhou L; Li Y; Wang T; Ma X
    Front Oncol; 2022; 12():851367. PubMed ID: 35359358
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DL4Burn: Burn Surgical Candidacy Prediction using Multimodal Deep Learning.
    Rambhatla S; Huang S; Trinh L; Zhang M; Long B; Dong M; Unadkat V; Yenikomshian HA; Gillenwater J; Liu Y
    AMIA Annu Symp Proc; 2021; 2021():1039-1048. PubMed ID: 35308958
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The challenges of colposcopy for cervical cancer screening in LMICs and solutions by artificial intelligence.
    Xue P; Ng MTA; Qiao Y
    BMC Med; 2020 Jun; 18(1):169. PubMed ID: 32493320
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hybrid Transfer Learning for Classification of Uterine Cervix Images for Cervical Cancer Screening.
    Kudva V; Prasad K; Guruvare S
    J Digit Imaging; 2020 Jun; 33(3):619-631. PubMed ID: 31848896
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Review of Computational Methods for Cervical Cells Segmentation and Abnormality Classification.
    Conceição T; Braga C; Rosado L; Vasconcelos MJM
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31618951
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An Observational Study of Deep Learning and Automated Evaluation of Cervical Images for Cancer Screening.
    Hu L; Bell D; Antani S; Xue Z; Yu K; Horning MP; Gachuhi N; Wilson B; Jaiswal MS; Befano B; Long LR; Herrero R; Einstein MH; Burk RD; Demarco M; Gage JC; Rodriguez AC; Wentzensen N; Schiffman M
    J Natl Cancer Inst; 2019 Sep; 111(9):923-932. PubMed ID: 30629194
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Automatic Approach for Cervical Cancer Detection and Segmentation Using Neural Network Classifier.
    P E; M S
    Asian Pac J Cancer Prev; 2018 Dec; 19(12):3571-3580. PubMed ID: 30583685
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Image Registration based Cervical Cancer Detection and Segmentation Using ANFIS Classifier.
    Jaya BK; Kumar SS
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3203-3209. PubMed ID: 30486611
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multifeature Quantification of Nuclear Properties from Images of H&E-Stained Biopsy Material for Investigating Changes in Nuclear Structure with Advancing CIN Grade.
    Konstandinou C; Glotsos D; Kostopoulos S; Kalatzis I; Ravazoula P; Michail G; Lavdas E; Cavouras D; Sakellaropoulos G
    J Healthc Eng; 2018; 2018():6358189. PubMed ID: 30073048
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Andriod Device-Based Cervical Cancer Screening for Resource-Poor Settings.
    Kudva V; Prasad K; Guruvare S
    J Digit Imaging; 2018 Oct; 31(5):646-654. PubMed ID: 29777323
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multi-feature based Benchmark for Cervical Dysplasia Classification Evaluation.
    Xu T; Zhang H; Xin C; Kim E; Long LR; Xue Z; Antani S; Huang X
    Pattern Recognit; 2017 Mar; 63():468-475. PubMed ID: 28603299
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multimodal entity coreference for cervical dysplasia diagnosis.
    Song D; Kim E; Huang X; Patruno J; Munoz-Avila H; Heflin J; Long LR; Antani S
    IEEE Trans Med Imaging; 2015 Jan; 34(1):229-45. PubMed ID: 25167547
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cervicography: adjunctive cervical cancer screening by primary care clinicians.
    Ferris DG; Payne P; Frisch LE; Milner FH; diPaola FM; Petry LJ
    J Fam Pract; 1993 Aug; 37(2):158-64. PubMed ID: 8336097
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HPV testing in the evaluation of the minimally abnormal Papanicolaou smear.
    Apgar BS; Brotzman G
    Am Fam Physician; 1999 May; 59(10):2794-801. PubMed ID: 10348071
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Performance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results.
    Reuschenbach M; Clad A; von Knebel Doeberitz C; Wentzensen N; Rahmsdorf J; Schaffrath F; Griesser H; Freudenberg N; von Knebel Doeberitz M
    Gynecol Oncol; 2010 Oct; 119(1):98-105. PubMed ID: 20619445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.